Clinical trial
Flavonoid Supplementation and Endothelial Function
NCT00331227 · Wake Forest University Health Sciences, Other · Completed
Key facts
| NCT number | NCT00331227 |
|---|---|
| Title | Flavonoid Supplementation and Endothelial Function |
| Official title | Effect of Supplemental Flavonoids on Endothelial Function, Lipids, and Markers of Inflammation |
| Lead sponsor | Wake Forest University Health Sciences, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Healthy |
| Intervention type | Drug |
| Interventions | Isotonix OPC-3 (flavonoid supplement) |
| Enrollment | 25 |
| Start date | May 1, 2006 |
| Completion | Dec 1, 2006 |
| First posted | May 29, 2006 |
| Last update posted | Apr 25, 2022 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: